Vincerx Pharma, Inc.

Vincerx Pharma, Inc. filed an S-1 registration statement with the SEC on January 29, 2021, bearing accession number 0001193125-21-022824, in connection with its business combination with LifeSci Acquisition Corp., a blank-check company sponsored by LifeSci Capital that completed its IPO in 2019. The resulting public company trades on Nasdaq under the ticker VINC and operates in the biopharmaceutical sector with a clinical focus on oncology, particularly hematological malignancies and solid tumors. The S-1 formalized share registration following the closing of the SPAC merger, marking Vincerx's transition to a publicly listed entity. Sign up at SpacDesk for full filing histories, sponsor profiles, and deal analytics across the SPAC market.